Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Dexamethasone results

press releases

16 June 2020

Statement from the Chief Investigators: low-cost dexamethasone reduces death by up to one third in hospitalised patients with severe respiratory complications of COVID-19

Comunicado dos Pesquisadores Principais do estudo “Avaliação randomizada de terapias para a COVID-19” (RECOVERY) sobre dexametasona, 16 de junho de 2020

Comunicado de prensa de la Universidad de Oxford: Dexametasona reduce la mortalidad hasta un tercio en pacientes hospitalizados con complicaciones severas por COVID-19

publications

The preliminary results of the dexamethasone comparison have been published on medRxiv. They have also been submitted to a major peer-reviewed journal.